Chromosome aberrations induced in human lymphocytes by radiation from 252Cf

Area of Science:

• Radiobiology
• Radiation Oncology
• Medical Physics

Background:

• Understanding the biological effects of Californium-252 (252Cf) neutron radiation is crucial for its therapeutic applications.
• High Linear Energy Transfer (LET) radiation, like neutrons, has complex dose-response relationships for DNA damage.
• Comparative studies with known radiation sources (e.g., 60Co, 226Ra) are essential for evaluating relative biological effectiveness (RBE).

Purpose of the Study:

• To determine the in vitro dose-response curves for unstable chromosome aberrations induced by 252Cf neutron radiation in human lymphocytes.
• To compare the RBE of 252Cf with 60Co gamma radiation and assess its depth-dependent biological effectiveness.
• To evaluate the potential of 252Cf radiation for cancer treatment, particularly for large tumors.

Main Methods:

• In vitro dose-response experiments using human lymphocytes exposed to 252Cf neutron radiation.
• Analysis of unstable chromosome aberrations and fitting yields to linear models (Y=aD).
• Comparison of 252Cf aberration induction with depth in a phantom against 226Ra gamma radiation and depth-damage calculations.

Main Results:

• Aberration yields for 252Cf neutrons followed a linear dose-response (Y=aD), consistent with the single-track model for high LET radiation.
• The RBE of 252Cf relative to 60Co gamma radiation was 27 at very low doses, decreasing to 6 at higher doses.
• 252Cf radiation's RBE increased with distance from the source in a phantom, indicating greater effectiveness at greater depths.

Conclusions:

• The linear dose-response and high RBE of 252Cf neutrons support their use in radiotherapy.
• The depth-dependent increase in RBE suggests 252Cf may be advantageous for treating larger, deeper tumors.
• Further research into 252Cf's biological effects can optimize its clinical application in radiation oncology.